Introduction
============

*Staphylococcus epidermidis* is the most abundant coagulase-negative staphylococci (CoNS) isolated from humans. This organism is a part of the normal flora of human skin and mucosa, with a capacity to cause disease in individuals with immune impairment, or in those with injury caused by foreign bodies \[[@b1-ophrp-09-0160]\]. In recent years, due to increased medical interventions, such as the use of vascular catheters and prosthetic device implants, the prevalence of infections caused by *S epidermidis* has considerably increased \[[@b2-ophrp-09-0160],[@b3-ophrp-09-0160]\]. Consequently, this organism is increasingly isolated and identified as a pathogen causing nosocomial sepsis; it accounts for approximately 30% of all nosocomial bloodstream infections \[[@b4-ophrp-09-0160]\]. This organism is also associated with a variety of clinical manifestations, including late sepsis in premature infants, central nervous system shunt infection, endocarditis, urinary tract infection, surgical site infection, and endophthalmitis \[[@b1-ophrp-09-0160]\].

Although *S epidermidis* is an opportunistic organism, this microorganism has several virulence factors, such as hemolysin, lipase, protease, lecithinase, DNase and toxins \[[@b5-ophrp-09-0160]\]. One of the special features of *S epidermidis* is the ability to adhere to polymeric surfaces and subsequently form a biofilm \[[@b6-ophrp-09-0160]\]. Strong binding of the bacterial biofilm to polymeric surfaces is the 1^st^ step of intravascular catheter-related bacteremia and other device-associated infections, leading to sepsis \[[@b7-ophrp-09-0160]\]. In the biofilm there are layers embedded in a matrix of extracellular polysaccharide (slime), which facilitates the adhesion of bacteria onto surfaces, protects them from the host immune response, and serves as an efficient barrier against antimicrobials. Therefore, eradication of bacteria within biofilms is difficult, as the tolerance to antibiotics eventually leads to the removal of contaminated devices \[[@b3-ophrp-09-0160],[@b6-ophrp-09-0160]\].

Biofilm formation is regulated by the expression of polysaccharide intercellular adhesion (PIA) \[[@b6-ophrp-09-0160]\]. PIA is composed of β -1,6 *N*- acetyl glucosamine and is responsible for cell to cell adhesion and is necessary for biofilm formation in *S epidermidis* strains \[[@b6-ophrp-09-0160],[@b7-ophrp-09-0160]\]. PIA is encoded by the chromosomal intercellular adhesion (*ica*) locus, consisting of the *icaADBC* structural and *icaR* regulatory genes \[[@b8-ophrp-09-0160]\]. Amongst them, the *icaA* and *icaD* genes have been reported to play a central role in biofilm production \[[@b9-ophrp-09-0160]\], having enzymatic activity (N-acetylglucosaminyltransferase). *icaA* alone has negligible enzymatic activity \[[@b7-ophrp-09-0160]\], but simultaneous expression with *icaD* initiates activity of N-acetylglucosaminyltransferase and produces oligomeres with a length of 20 residues \[[@b6-ophrp-09-0160],[@b7-ophrp-09-0160]\].

There are various methods to evaluate biofilm formation in bacteria, such as qualitative Congo red agar (CRA), the tube method (TM) \[[@b10-ophrp-09-0160]\], and analysis on quantitative micro titer plates (MTP) \[[@b3-ophrp-09-0160],[@b11-ophrp-09-0160]\]. There is controversy amongst scientists regarding which method is the most reliable for assessing biofilm formation \[[@b3-ophrp-09-0160],[@b6-ophrp-09-0160],[@b10-ophrp-09-0160]\]. However, the microtiter plate biofilm formation assay has been identified as a valuable method \[[@b3-ophrp-09-0160], [@b8-ophrp-09-0160],[@b12-ophrp-09-0160]\]. Furthermore, molecular DNA-based techniques, such as PCR have been used recently to better understand the molecular mechanisms of biofilm formation \[[@b6-ophrp-09-0160]\].

A better understanding of the mechanisms of adhesion by microorganisms to produce a microbial biofilm could identify new procedures to counteract the numerous infections associated with biofilm growth. According to previous studies, controversies involve the selection of a reliable approach to identify biofilm formation in bacteria. In this regard, the aim of the present study was to determine biofilm formation and the presence of *icaA* and *icaD* genes in *S epidermidis* clinical isolates, and evaluate the reliability of CRA, TM, and MTP phenotypic methods for detection of a biofilm.

Materials and Methods
=====================

1. Bacterial isolates
---------------------

Sayyad Shirazi hospital is university-affiliated teaching medical center in Gorgan, Northern Iran. In a cross-sectional study between 2013 and 2014, various clinical specimens from patients admitted to Sayyad Shirazi hospital were collected. All specimens were stored in brain-heart infusion broth medium (Merck, Darmstadt, Germany) and taken directly to the diagnostic microbiological laboratory, Department of Microbiology, School of Medicine All specimens were cultured on blood agar (Merck, Darmstadt, Germany) and incubated at 37°C for 24 hours. Colonies that had grown were identified as *S epidermidis* by using the standard microbiological and biochemical tests, and then confirmed by amplifying and sequencing the *tuf* gene \[[@b13-ophrp-09-0160]\].

2. Microtiter plate method
--------------------------

MTP test was performed according to the published method \[[@b14-ophrp-09-0160]\]. Briefly, a 0.5 McFarland standard was prepared from an overnight culture grown in trypticase soy broth (Merck, Darmstadt, Germany) containing 1% glucose (Merck, Darmstadt, Germany), 200 μL aliquots were added to a 96-well tissue culture plate (JET BIOFIL, Guangzhou, China) and incubated for 24 hours at 37°C. The supernatant was removed from each well and the plate was washed 4 times with phosphate buffer saline. The plate was incubated at 65°C for 1 hour until dry. Adherent cells attached to each well were stained with 0.1% crystal violet (Sigma Chemical Co., St Louis, MO, USA). The plate was washed twice with deionized water to remove the excess dye, and then 100 mL of 70% ethanol with 10% isopropyl alcohol, was added. The optical density of the adherent biofilm was read at 570 nm by an ELISA plate reader (BioTek, Bad Friedrichshall, Germany). Each test was performed in triplicate. The results were interpreted based on the criteria shown in [Table 1](#t1-ophrp-09-0160){ref-type="table"} \[[@b15-ophrp-09-0160]\]. As described by Thilakavathy et al \[[@b8-ophrp-09-0160]\], strains were categorized as biofilm positive when a strong or moderate biofilm was detected.

3. Congo red agar method
------------------------

Detection of bioﬁlm formation in all isolates was studied by the CRA method according to the protocol described by Freeman et al \[[@b10-ophrp-09-0160]\]. CRA medium was prepared with brain heart infusion broth (Merck, Darmstadt, Germany) 37 g/L, sucrose (Merck, Darmstadt, Germany) 50 g/L, agar-agar (Pronadisa, Laboratories Conda, S.A., Madrid, Spain) 10 g/L, and Congo red dye (Merck, Darmstadt, Germany) 0.8 g/L. Prepared CRA plates were inoculated with a 0.5 McFarland turbidity standard of microorganism and incubated aerobically at 37°C for 24 hours. For color evaluation of colonies, a 5-colourimetric scale method was used. Biofilm-positive isolates appeared as dry opaque black and bright black colonies, while biofilm-negative variants developed a red, pink with or without a darkening at the center, or Bordeaux red colonies \[[@b6-ophrp-09-0160]\].

4. Tube method
--------------

An overnight culture, grown in nutrient agar (Merck, Darmstadt, Germany) was inoculated in trypticase soy broth supplemented with 1% glucose contained in 2 mL plastic tubes. The cultures were incubated overnight at 37°C, following which the tubes were decanted gently, washed with phosphate buffer saline and air-dried. The tubes were stained using 0.1% crystal violet (Sigma Chemical Co., St Louis, MO, USA), washed with deionized water to remove the unbound stain, and air dried in an inverted position. Scoring for the tube method was performed using the control strains. The criteria for production of biofilm in isolates was when a visible film lined the wall and the bottom of the tube. The amount of biofilm formed was categorized as negative, weak, moderate, or strong \[[@b12-ophrp-09-0160]\]. A biofilm positive strain had a strong or moderate biofilm.

5. Polymerase chain reaction (PCR)
----------------------------------

The presence of *icaA* and *icaD* genes were analyzed by PCR using specific primers for each. The PCR primers for *icaA* gene were as follows: forward, 5'-ACACTTGCTGGCGCAGTCAA-3'; reverse, 5'-TCTGGAACCAACATCCAACA-3'. The primer sequences for amplification of the *icaD* gene were as follows: forward, 5'-ATGGTCAAGCCCAGACAGAG-3'; reverse, 5'-AGTATTTTCAATGTTTAAAGCAA-3' \[[@b16-ophrp-09-0160]\]. DNA extraction was performed by phenol chloroform/isoamyl alcohol method as described previously \[[@b17-ophrp-09-0160]\]. The reaction volume was 25 μL, and the reaction mixture contained 1× buffer \[10 mM Tris-HCl (pH = 8.3), 50 mM KCl, 0.01% Triton X-100\], 0.2 mM of each dNTP, 2 mM MgCl~2,~ 1 μM of each primer, 1 U *Taq* polymerase, and 0.1 μg of template DNA. Amplification of both genes was performed in a Mastercycler (Eppendorf, Hamburg, Germany) using the following thermal conditions: initial denaturation at 94°C for 4 minutes, followed by 35 cycles of denaturation at 94°C for 30 seconds, annealing at 56°C for 30 seconds, extension at 72°C for 30 seconds, and a final extension at 72°C for 10 minutes. PCR products were electrophoresed on 1.5% agarose gel (Sigma Chemical Co., St Louis, MO, USA), stained with SYBR Safe DNA Gel Stain (Thermo Fisher Scientific, USA) and visualized by UV illuminator (SABZ Biomedical, Tehran, Iran).

6. Statistical analysis
-----------------------

Data were analyzed by SPSS16.0 software. Chi-square test was used to determine significance. In all cases, *p* \< 0.05 was considered statistically significant. The validity of studied methods (sensitivity and specificity), and metrics for test performance, including positive (negative) predictive value (PPV/NPV), and positive (negative) likelihood ratio (PLR/NLR), were compared against the MTP gold standard method.

Results
=======

1. Bacterial isolates
---------------------

There were 41 *S epidermidis* isolates obtained from various biological materials, including blood (61%, 25/41), tracheal aspirate (14.6%, 6/41), eye exudates (14.6%, 6/41), and urine (9.7%, 4/41). The majority of *S epidermidis* was isolated from patients hospitalized in ICU (31.7%, 13/41) and pediatric units (24.4%, 10/41). The percentage of isolates recovered from males and females were 39% (16/41) and 61% (25/41), respectively. The highest proportions of isolates (46.3%, 19/41) were from patients 20 years or younger, followed by patients 45 years and older (36.5%, 15/41).

2. Detection of the biofilm-producing phenotype
-----------------------------------------------

[Table 2](#t2-ophrp-09-0160){ref-type="table"} shows the results of biofilm formation in *S epidermidis* isolates using 3 methods: MTP, TM and CRA . The percentage of biofilm-producing *S epidermidis* in both MTP and TM assays was 53.6% (22/41), 19.5% of isolates were identified as strong biofilm producers by MTP assay compared to 14.6% of those detected by TM.

Blood isolates were the highest proportion with a biofilm phenotype (60%, 15/25) in both MTP and TM assays. In addition, 84.6% (11/13) and 71.4% (5/7) of isolates obtained from ICU and internal medicine wards, were biofilm-positive by MTP and TM, respectively. Using the CRA method, 24.4% (10/41) of isolates had a biofilm phenotype: 19.5% (8/41) of isolates produced bright black colonies and 4.8% (2/41) isolates produced dry opaque colonies; whereas 75.6% (31/41) isolates were identified as having a non-biofilm phenotype, compared with 29.3% (12/41), 14.6% (6/41), and 31.7% (13/41) isolates that produced red, pink, and Bordeaux red colonies, respectively. However, the CRA method did not correlate with the MTP assay, where only 9.7% (4/41) of isolates had a biofilm phenotype identified by both CRA and MTP.

In addition, biofilm-forming ability in *S epidermidis* isolates by 3 phenotypic assays did not correlate with patient demographics and characteristics, including clinical specimen type, and patient's age and gender. However, there was a significant correlation between the ability for biofilm formation using the MTP method and the hospital ward (*p* = 0.04).

3. Detection of ica genes
-------------------------

Generally, *S epidermidis* isolates were positive for *icaA* \[100% (41/41)\] and *icaD* genes \[95.1% (39/41)\] and had bands of 188 bp and 198 bp, respectively ([Figure 1](#f1-ophrp-09-0160){ref-type="fig"}). With regard to correlation of phenotypic characteristics with the presence of *icaAD* genes, isolates were non-biofilm forming when assessed by MTP \[46.3% (19/41)\], TM \[43.9% (18/41)\] and CRA \[70.7% (29/41)\], but were positive for *icaA* or *icaD* genes. On the other hand, only 4.8% (2/41) and 2.4% (1/41) of isolates were biofilm forming by MTP and TM, respectively, in spite of the absence of *ica* gene.

4. Validity of tests
--------------------

The specificity and sensitivity of TM, CRA and PCR methods in comparison to the MTP assay are shown in [Table 3](#t3-ophrp-09-0160){ref-type="table"}. Other parameters, such as PPV, NPV, PLR, and NLR were also calculated. Sensitivity and specificity of TM was estimated to be 64% and 58%, respectively. Although CRA and PCR had a relatively acceptable specificity (each 68%), they exhibited low sensitivity (18% and 45.5%, respectively) to identify biofilm phenotype, when compared to MTP.

Discussion
==========

The ability to adhere to the surfaces of biomaterials, and consequently form a biofilm is one of the most important factors for *S epidermidis* to induce serious nosocomial infections \[[@b3-ophrp-09-0160],[@b7-ophrp-09-0160]\]. So, detection of biofilm-forming strains of *S epidermidis* by an appropriate method and suppression of their adhesive mechanisms may be useful for development of anti-adhesive coatings for prosthetic medical devices and in drug development.

The MTP is a quantitative gold standard method for detection of biofilm formation \[[@b12-ophrp-09-0160]\]. In this study, 53.6% of *S epidermidis* were found with a biofilm phenotype, which is comparable to results by Ebrahimi et al in Iran \[[@b18-ophrp-09-0160]\], and Ninin et al in France \[[@b19-ophrp-09-0160]\], but lower than rates reported in Egypt \[[@b20-ophrp-09-0160]\] and Thailand \[[@b21-ophrp-09-0160]\]. These discrepancies could be due to spectrophotometric procedures and clinical specimen sources \[[@b15-ophrp-09-0160]\].

In the present study, only 24.4% of isolates tested, showed a biofilm phenotype on CRA plates, which was consistent with the study by El--Mahallawy et al \[[@b22-ophrp-09-0160]\], where 23.5% of *S epidermidis* isolated from blood cultures formed a biofilm. In contrast, El-Khier et al \[[@b15-ophrp-09-0160]\], reported that 43.6% of isolates from orthopedic prosthetic implants, were bioﬁlm-producers. As previously reported \[[@b15-ophrp-09-0160]\] such contradictions may be due to multifactorial reasons, and can result from the differences in the origin of the specimens, CRA composition, incubation conditions, and also the interpretation of the color of the colonies. In addition, with respect to the specificity and sensitivity of methods used for assessing the biofilm formation, the results in this study are consistent with those reported by Melo et al \[[@b23-ophrp-09-0160]\] and Oliveira et al \[[@b6-ophrp-09-0160]\], where MTP and TM showed higher sensitivity and specificity than CRA.

It has been demonstrated that there are some correlations between the biofilm-forming capacity of bacteria, and patient demographics and characteristics \[[@b24-ophrp-09-0160]--[@b26-ophrp-09-0160]\]. In the case of *S epidermidis*, previous studies found a significant correlation between the type of biological samples, and the biofilm production. Sanchez et al \[[@b27-ophrp-09-0160]\] in the United States reported that clinical strains isolated from non-fluid sites, including superficial/deep tissue, bone, and respiratory tract, on average had a significantly higher proportion of biofilm positive strains, compared to those isolates from host fluids, including blood or urine. Solati et al \[[@b28-ophrp-09-0160]\] also reported that urinary isolates more frequently formed biofilms compared with isolates from other clinical samples. Thummeepak et al \[[@b29-ophrp-09-0160]\] reported that there were significant differences in the biofilm producing capacity amongst isolates from various hospital wards. Similarly, this study detected a high capacity to form a biofilm (using the MTP method) which correlated with the hospital wards. However, other factors, such as gender, presence of invasive devices, and prior or prolonged hospitalization have also been shown to be associated with biofilm production by microbes \[[@b24-ophrp-09-0160]--[@b26-ophrp-09-0160]\].

Consistent with Gad et al \[[@b20-ophrp-09-0160]\], *icaAD* genes were detected in 95.1% of *S epidermidis* isolates in this current study. In addition, there are some studies to support the appearance of biofilm-negative variants with both *icaA* and *icaD* genes \[[@b1-ophrp-09-0160],[@b30-ophrp-09-0160]\]. Similarly, we also found such variants amongst the *S epidermidis* isolates studied. Presence of these genes without biofilm production can be explained by chromosomal point mutations or a negative translational or post-translational regulation, affecting the production of biofilm-associated proteins \[[@b9-ophrp-09-0160]\]. In addition, where 2 isolates were identified as biofilm-producer by the phenotypic method but the *ica* gene was absent, is suggesting that this may be due to an *ica* gene-independent control of biofilm formation/adhesion process in staphylococci \[[@b31-ophrp-09-0160]\].

This study may be limited by the small number of isolates, the lack of comprehensive clinical data of the patients, as well as the lack of evaluation of *icaB* and *icaC* genes. Furthermore, this study indicates that determination of expression levels of *ica* genes by quantitative real-time PCR may help assess the role of each corresponding gene in the production of biofilm.

In conclusion, although the TM method has the ability to detect biofilm-producing *S epidermidis* to the same level as the MTP, the latter would be more appropriate, as it is less costly as well as less likely that results would be misinterpreted. In contrast, CRA, although easier and faster to perform, showed low sensitivity, and therefore, cannot be recommended as a screening test for identifying biofilm production by *S epidermidis*. Moreover, our results revealed that the presence of *ica* genes alone does not lead to biofilm formation. On the other hand, the biofilm-forming ability of some isolates in the absence of *ica* gene emphasizes the importance of *ica*-independent mechanisms of biofilm formation. Due to increased biomaterial-related infections caused by biofilm-forming pathogens, the use of a reliable method to specifically detect biofilms would help to identify potentially infectious bacteria and aid the therapeutic decision-making in affected patients.
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![Agarose gel electrophoresis of *icaA* (A) and *icaD* (B) genes in *S epidermidis* isolates. Lanes 1--3 = PCR products of the corresponding genes; M= 50 bp DNA marker; N = negative control; P = positive control.](ophrp-09-0160f1){#f1-ophrp-09-0160}

###### 

Interpretation of biofilm by the microtiter plate method.

  Mean OD value                                             Biofilm formation
  --------------------------------------------------------- -------------------------------------------------------
  OD ≤ ODc [\*](#tfn1-ophrp-09-0160){ref-type="table-fn"}   None
  ODc \< OD ≤ 2× ODc                                        Weak
  2× ODc \< OD ≤ 4× ODc                                     Moderate[†](#tfn2-ophrp-09-0160){ref-type="table-fn"}
  4× ODc \< OD                                              Strong[†](#tfn2-ophrp-09-0160){ref-type="table-fn"}

Mean OD of negative control + 3× SD of negative control.

Isolates with strong or moderate biofilm were considered biofilm producers.

OD = optical density; ODc = optical density cut off.

###### 

Results of three biofilm formation detection assays and ica genes detection among the 41 *S epidermidis* clinical isolates.

  Characteristics (No.)      No. (%) of biofilm formation   No. (%) of gene present                          
  -------------------------- ------------------------------ ------------------------- ----------- ---------- -----------
  Clinical specimen                                                                                          
                                                                                                             
   Blood (25)                15 (60)                        15 (60)                   6 (24)      25 (100)   23 (92)
   Tracheal aspirate (6)     3 (50)                         4 (67)                    1 (17)      6 (100)    6 (100)
   Eye exudate (6)           3 (50)                         3 (50)                    2 (33)      6 (100)    6 (100)
   Urine (4)                 1 (25)                         0                         1 (25)      4 (100)    4 (100)
   *p*                       0.5                            0.15                      0.12        0.36       
                                                                                                             
  Hospital ward                                                                                              
                                                                                                             
   ICU (13)                  11 (84.6)                      6 (46.1)                  3 (23)      13 (100)   12 (92.3)
   Pediatric (10)            4 (40)                         5 (50)                    3 (30)      10 (100)   10 (100)
   Internal medicine (7)     3 (42.8)                       5 (71.4)                  1 (14.2)    7 (100)    6 (86)
   Neurology (5)             2 (40)                         3 (60)                    2 (40)      5 (100)    5 (100)
   Infectious diseases (4)   2 (50)                         2 (50)                    0           4 (100)    4 (100)
   Women's surgical (2)      0                              1(50)                     1 (50)      2 (100)    2 (100)
   *p*                       0.04                           0.075                     0.074       0.11       
                                                                                                             
  Patient age (y)                                                                                            
                                                                                                             
   \< 20 (19)                11 (57.9)                      9 (47.3)                  6 (31.6)    19 (100)   18 (95)
   20 -- 45 (7)              4 (57.1)                       6 (85.7)                  1 (14.2)    7 (100)    7 (100)
   \> 45 (15)                7 (46.7)                       7 (46.7)                  3 (20)      15 (100)   14 (93)
   *p*                       0.915                          0.218                     0.703       0.373      
                                                                                                             
  Patient gender                                                                                             
                                                                                                             
   Female (25)               13 (52)                        12 (48)                   9 (36)      25 (100)   24 (96)
   Male (16)                 9 (56.2)                       10 (62.5)                 1 (6.2)     16 (100)   15 (94)
   *p*                       0.79                           0.36                      0.06        0.48       
                                                                                                             
   Total (41)                22 (53.6)                      22 (53.6)                 10 (24.4)   41 (100)   39 (95.1)

CRA = congo red agar; MTP = microtiter plate; TM = tube method.

###### 

Performance indices used for the evaluation of biofilm formation using TM, CRA and PCR methods.

  Method   \% of statistical parameter                           
  -------- ----------------------------- ---- ------ ---- ------ ------
  TM       64                            58   64     58   1.52   0.62
  CRA      18                            68   40     42   0.56   1.2
  PCR      45.5                          68   62.5   52   1.42   0.8

CRA = congo red agar; NLR = negative likelihood ratio; NPV = negative predictive value; PCR = polymerase chain reaction; PLR = positive likelihood ratio; PPV = positive predictive value; SN = sensitivity; SP = specificity; TM = tube method.
